Orofacial clefts and spina bifida: N-acetyltransferase phenotype, maternal smoking, and medication use

Teratology

Volumn 66, Issue 5, 2002, Pages 260-266

  Van Rooij, Iris A L M ^a   Groenen, Pascal M W ^a   Van Drongelen, Merel ^a   Te Morsche, René H M ^a   Peters, Wilbert H M ^a   Steegers Theunissen, Régine P M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CAFFEINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ARYLAMINE ACETYLTRANSFERASE; EMETIC AGENT;

ACETYLATION; ADULT; ARTICLE; BIOTRANSFORMATION; CLEFT FACE; CLEFT LIP FACE PALATE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIFACTORIAL GENETIC DISORDER; PHENOTYPE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SPINA BIFIDA; STATISTICAL ANALYSIS; CASE CONTROL STUDY; CLEFT LIP; CLEFT PALATE; COMPARATIVE STUDY; DRUG THERAPY; FETOMATERNAL TRANSFUSION; GENETICS; LIFESTYLE; MATERNAL AGE; NEURAL TUBE DEFECT; PARITY; PREGNANCY;

ANALGESICS; ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ARYLAMINE N-ACETYLTRANSFERASE; CASE-CONTROL STUDIES; CLEFT LIP; CLEFT PALATE; DRUG THERAPY; EMETICS; FEMALE; HUMANS; LIFE STYLE; MATERNAL AGE; MATERNAL-FETAL EXCHANGE; PARITY; PHENOTYPE; PREGNANCY; RISK FACTORS; SMOKING; SPINAL DYSRAPHISM;

EID: 0036842182     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/tera.10096     Document Type: Article

References (37)

1. Abrishamchian AR, Khoury MJ, Calle EE. 1994. The contribution of maternal epilepsy and its treatment to the etiology of oral clefts: A population based case-control study. Genet Epidemiol 11:343-351.
2. Beaty TH, Wang H, Hetmanski JB, Fan YT, Zeiger JS, Liang KY, Chiu YF, Vanderkolk CA, Seifert KC, Wulfsberg EA, Raymond G, Panny SR, McIntosh I. 2001. A case-control study of nonsyndromic oral clefts in Maryland. Ann Epidemiol 11:434-442.
3. Brockmöller J, Cascorbi I, Kerb R, Sachse C, Roots I. 1998. Polymorphism in xenobiotic conjugation and disease predisposition. Toxicol Lett 102-103:173-183.
4. Carmichael SL, Shaw GM. 1999. Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet 86:242-244.
5. Carter CO. 1969. Multifactorial inheritance revisited. In: Fraser FR, McKusick VA, editors. Congenital Malformations. Amsterdam: Excerpta Medica. p. 227-237.
6. Cascorbi I, Drakoulis N, Brockmöller J, Maurer A, Sperling K, Roots I. 1995. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: Correlation with phenotypic activity. Am J Hum Genet 57:581-592.
7. Christensen K, Olsen J, Norgaard-Pedersen B, Basso O, Støvring H, Milhollin-Johnson L, Murray JC. 1999. Oral clefts, transforming growth factor alpha gene variants, and maternal smoking: A population-based case-control study in Denmark, 1991-1994. Am J Epidemiol 149:248-255.
8. Chung KC, Kowalski CP, Kim HM, Buchman SR. 2000. Maternal cigarette smoking during pregnancy and the risk of having a child with cleft lip/palate. Plast Reconstr Surg 105:485-491.
9. Ericson A, Källén B, Löfkvist E. 1988. Environmental factors in the etiology of neural tube defects: A negative study. Environ Res 45: 38-47.
10. Finnell RH, Greer KA, Barber RC, Piedrahita JA, Shaw GM, Lammer EJ. 1998. Neural tube and craniofacial defects with special emphasis on folate pathway genes. Crit Rev Oral Biol Med 9:38-53.
11. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. 2000. Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343:1608-1614.
12. Hernández-Díaz S, Werler MM, Walker AM, Mitchell AA. 2001. Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 153:961-968.
13. Hill L, Murphy M, McDowall M, Paul AH. 1988. Maternal drug histories and congenital malformations: Limb reduction defects and oral clefts. J Epidemiol Community Health 42:1-7.
14. Källén K. 1996. Maternal smoking and orofacial clefts. Cleft Palate Craniofac J 34:11-16.
15. Källén K. 1998. Maternal smoking, body mass index, and neural tube defects. Am J Epidemiol 147:1103-1111.
16. King CM, Land SJ, Jones RF, Debiec-Rychter M, Lee MS, Wang CY. 1997. Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines. Mutat Res 376:123-128.
17. Khoury MJ, Gomez-Farias M, Mulinare J. 1989. Does maternal cigarette smoking during pregnancy cause cleft lip and palate in offspring? Am J Dis Child 143:333-337.
18. Leck I. 1974. Causation of neural tube defects: Clues from epidemiology. Br Med Bull 30:158-163.
19. Lieff S, Olshan AF, Werler M, Strauss RP, Smith J, Mitchell A. 1999. Maternal cigarette smoking during pregnancy and risk of oral clefts in newborns. Am J Epidemiol 150:683-694.
20. Lindhout D, Schmidt D. 1986. In utero exposure to valproate and neural tube defects. Lancet 1:1392-1393.
21. Lorente C, Cordier S, Goujard J, Aymé S, Bianchi F, Calzolari E, De Walle HEK, Knill-Jones R, Occupational Exposure and Congenital Malformation Working Group. 2000. Tobacco and alcohol use during pregnancy and risk of oral clefts. Am J Public Health 90:415-419.
22. Malloy MH, Kleinman JC, Bakewell JM, Schramm WF, Land GH. 1989. Maternal smoking during pregnancy: No association with congenital malformations in Missouri 1980-83. Am J Public Health 79:1243-1246.
23. Minchin RF. 1995. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. Biochem J 307:1-3.
24. Romitti PA, Lidral AC, Munger RG, Daack-Hirsch S, Burns TL, Murray JC. 1999. Candidate genes for nonsyndromic cleft lip and palate and maternal cigarette smoking and alcohol consumption: Evaluation ofgenotype-environment interactions form a population-based case-control study of orofacial clefts. Teratology 59:39-50.
25. Saxén I. 1975. Associations between oral clefts and drugs taken during pregnancy. Int J Epidemiol 4:37-44.
26. Shaw GM, Velie EM, Morland KB. 1996a. Parental recreational drug use and risk for neural tube defects. Am J Epidemiol 144:1155- 1160.
27. Shaw GM, Wasserman CR, Lammer EJ, O'Malley CD, Murray JC, Basart AM, Tolarova MM. 1996b. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet 58:551-561.
28. Stanley LA, Copp AJ, Pope AJ, Rolls S, Smelt V, Perry VH, Sim E. 1998. Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain. Teratology 58:174-182.
29. Tang BK, Kadar D, Qian L, Iriah J, Yip J, Kalow W. 1991. Caffeine as a metabolic probe: Validation of its use for acetylator phenotyping. Clin Pharmacol Ther 49:648-657.
30. van Rooij IALM, Wegerif MJM, Roelofs HMJ, Peters WHM, Kuijpers-Jagtman AM, Zielhuis GA, Merkus JMWM, Steegers-Theunissen RPM. 2001. Smoking, genetic polymorphisms in biotransformation enzymes and nonsyndromic oral clefting: A gene-environment interaction. Epidemiology 12:502-507.
31. Ward A, Summers MJ, Sim E. 1995. Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol 49:1759-1767.
32. Wasserman CR, Shaw GM, O'Malley CD, Tolarova MM, Lammer EJ. 1996. Parental cigarette smoking and risk for congenital anomalies of the heart, neural tube, or limb. Teratology 53:261-267.
33. Weber WW, Hein DW. 1985. N-acetylation pharmacogenetics. Pharmacol Rev 37:25-79.
34. Werler MM, Lammer EJ, Rosenberg L, Mitchell AA. 1990. Maternal cigarette smoking during pregnancy in relation to oral clefts. Am J Epidemiol 132:926-932.
35. Wormhoudt LW, Commandeur JNM, Vermeulen NPE. 1999. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-s-transferase, and epoxide hydrolase enzymes: Relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol 29: 59-124.
36. Wyszynski DF, Beaty TH, Meastri NE. 1996. Genetics of non-syndromic oral clefts revisited. Cleft Palate Craniofac J 33:406-417.
37. Wyszynski DF, Duffy DL, Beaty TH. 1997. Maternal cigarette smoking and oral clefts: A meta-analysis. Cleft Palate Craniofac J 34: 206-210.